These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36470572)

  • 21. Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience.
    Daniel F; Hassoun L; Husni M; Sharara A; Soweid A; Barada K; Haffar B; Massoud R; Shaib Y; Al-Hashash J; Bazarbachi A; El Cheikh J
    Curr Res Transl Med; 2019 Feb; 67(1):16-19. PubMed ID: 30206046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between IL-10 Gene -592(C→A) (rs1800872) SNP and GVHD after Allogeneic Hematopoietic Stem Cell Transplantation in Children].
    Lin JY; Wang K; Gao C; Liu SG; Qin MQ; Wang B; Zhu GH; Zheng HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):573-579. PubMed ID: 30998173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation.
    Matos C; Mamilos A; Shah PN; Meedt E; Weber D; Ghimire S; Hiergeist A; Gessner A; Dickinson A; Dressel R; Walter L; Stark K; Heid IM; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Kreutz M; Ghimire S
    Front Immunol; 2022; 13():1028850. PubMed ID: 36341397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship of tumor necrosis factor gene polymorphism and acute graft-versus-host disease after unrelated allogeneic hematopoietic stem cell transplantation].
    Jin L; Xiao HW; Lai XY; Wu GQ; Luo Y; Shi JM; Tan YM; Huang H
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):320-4. PubMed ID: 20627040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.
    Bueno F; Albert E; Giménez E; Piñana JL; Pérez A; Dolores Gómez M; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Buesa J; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
    J Med Virol; 2021 Aug; 93(8):4773-4779. PubMed ID: 33605457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological comparison between acute gastrointestinal-graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation.
    Ohwada S; Iida T; Hirayama D; Sudo G; Kubo T; Nojima M; Yamashita K; Yamano H; Nakase H
    PLoS One; 2018; 13(7):e0200627. PubMed ID: 30059537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease.
    Bogunia-Kubik K; Lange A
    Transplantation; 2005 Apr; 79(7):815-20. PubMed ID: 15818324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of p16INK4a and low expression of Bmi1 are associated with endothelial cellular senescence in the human cornea.
    Wang Y; Zang X; Wang Y; Chen P
    Mol Vis; 2012; 18():803-15. PubMed ID: 22509111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: A single-center pediatric series.
    Rosa M; Jarmoliński T; Miśkiewicz-Migoń I; Liszka K; Miśkiewicz-Bujna J; Panasiuk A; Frączkiewicz J; Ussowicz M
    Adv Clin Exp Med; 2022 Mar; 31(3):345-350. PubMed ID: 35212198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of patients developing acute gastro-intestinal graft-versus-host-disease: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    de Berranger E; Charbonnier A; Davy E; Dendonker C; Denis V; Desmier D; Farrugia C; Guenounou S; Guilbert Y; Jost E; L'hostette A; Rialland F; Taque S; Yafour N; Seguy D; Yakoub Agha I
    Bull Cancer; 2021 Dec; 108(12S):S30-S38. PubMed ID: 33966887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in situ local immune response, tumour senescence and proliferation in colorectal cancer.
    Roxburgh CS; Richards CH; Macdonald AI; Powell AG; McGlynn LM; McMillan DC; Horgan PG; Edwards J; Shiels PG
    Br J Cancer; 2013 Oct; 109(8):2207-16. PubMed ID: 24022192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SATB2, coordinated with CUX1, regulates IL-1β-induced senescence-like phenotype in endothelial cells by fine-tuning the atherosclerosis-associated p16
    Wu T; Wu Y; Jiang D; Sun W; Zou M; Vasamsetti SB; Dutta P; Leers SA; Di W; Li G
    Aging Cell; 2023 Feb; 22(2):e13765. PubMed ID: 36633253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CREG1 enhances p16(INK4a) -induced cellular senescence.
    Moolmuang B; Tainsky MA
    Cell Cycle; 2011 Feb; 10(3):518-30. PubMed ID: 21263217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.
    Kuba A; Raida L
    Mediators Inflamm; 2018; 2018():9451950. PubMed ID: 29785172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
    Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of gene polymorphisms on susceptibility to acute GVHD and survival of allogeneic HSCT recipients: IL-10 gene polymorphisms as a more accessible target to predict prognosis.
    Granero Farias M; Andrade Dos Santos C; de Mello Vicente B; Habigzang M; de Oliveira da Silva P; Emerim Lemos N; Dieter C; Paz A; Esteves Daudt L
    Hum Immunol; 2020 Jan; 81(1):18-25. PubMed ID: 31889553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16INK4a-induced senescence is disabled by melanoma-associated mutations.
    Haferkamp S; Becker TM; Scurr LL; Kefford RF; Rizos H
    Aging Cell; 2008 Oct; 7(5):733-45. PubMed ID: 18843795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice.
    Cardenas JC; Owens AP; Krishnamurthy J; Sharpless NE; Whinna HC; Church FC
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):827-33. PubMed ID: 21233453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXA1 mediates p16(INK4a) activation during cellular senescence.
    Li Q; Zhang Y; Fu J; Han L; Xue L; Lv C; Wang P; Li G; Tong T
    EMBO J; 2013 Mar; 32(6):858-73. PubMed ID: 23443045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Cho IH; Song YK; Kim MG; Han N; Kim T; Oh JM
    Hematology; 2015 Apr; 20(3):121-8. PubMed ID: 25116082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.